A Phase I Study Of Bind-014, A Psma-Targeted Nanoparticle Containing Docetaxel, In Patients With Refractory Solid Tumors.Daniel D. Von Hoff,Monica Mita,Peter Eisenberg,Patricia Lorusso,Glen Weiss,Jasgit Sachdev,Alain Mita, Susan Low,Jeff Hrkach,Jason Summa,Gregory Berk,Ramesh RamanathanCANCER RESEARCH(2013)引用 5|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要